• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过使用不同萃取介质的加速试验评估药用玻璃容器的分层倾向。

Delamination propensity of pharmaceutical glass containers by accelerated testing with different extraction media.

作者信息

Guadagnino Emanuel, Zuccato Daniele

机构信息

Scientific Advisor for Stevanato Group, Via Molinella 17, Piombino Dese (PD) 35017-Italy.

出版信息

PDA J Pharm Sci Technol. 2012 Mar-Apr;66(2):116-25. doi: 10.5731/pdajpst.2012.00853.

DOI:10.5731/pdajpst.2012.00853
PMID:22492597
Abstract

UNLABELLED

The delamination of pharmaceutical glass is a serious issue, as it can cause glass particles to appear in vials, a problem that has forced a number of drug product recalls in recent years. In Type I pharmaceutical glass vials, delamination occurs generally at the bottom and shoulder, where extensive flaming during the conversion process can favor a strong evaporation of alkali and borate species and the formation of heavily enriched silica layers. The contact with parenteral preparations dissolved in an alkaline medium increases the rate of glass corrosion, while the differential hydration of these layers can cause the detachment of flakes. The purpose of this study was to investigate the effect of the pH and the composition of the extraction solutions on the propensity of different glass types to delaminate. Repeated autoclave extractions at 121 °C were carried out on different glass types with different extraction media, including organic extractants like citric and glutaric acid. When vials were in contact with alkaline solutions and similarly aggressive media, an increase in silica extraction values indicated glass corrosion and an increasing risk for further delamination. Under such conditions expansion 33 glass is extensively corroded, showing high silica concentration and heavy flaking as compared to other glass types. Sulfur-treated glass also showed early flaking, even if SiO(2) concentration was very low. A similar ranking was observed with extractions carried out with glutaric and citric acids, but at far much higher SiO(2) concentration levels. Extractions with 0.9% KCl solution can be used as an accelerated test to highlight the propensity of a glass to delaminate, but in no case it can be taken as a guarantee that the glass will not delaminate when exposed to the pharmaceutical drug, whose extraction ability requires case-by-case study.

LAY ABSTRACT

How can injectable drug manufacturers prevent glass delamination? The issue of delamination is a serious one, as it can cause glass particles to appear in vials, a problem that has forced a number of drug product recalls in recent years. To combat this, pharmaceutical and biopharmaceutical manufacturers need to understand the reasons for glass delamination. The most recent cases of product recall due to the presence of particles in the filling liquid have involved borosilicate glass containers carrying drugs made of active components with known ability to corrode glass and to dissolve the silica matrix. Sometimes these ingredients are dissolved in an alkaline medium that dramatically increases the glass corrosion and potentially causes the issue. As this action is strongly affected by time and temperature, flaking may become visible only after a long incubation during storage and requires systematic monitoring to be detected at its early stage. If the nature of the filling liquid is the driving force of the phenomenon, other factors are of primary importance. The surface morphology created during vial forming is a key issue, being a function of the forming temperature that is higher in the cutting step and the forming of the bottom. Delamination occurs generally on the vial's bottom and shoulder, where extensive flaming can favor a strong evaporation of alkali and borate species and the formation of heavily enriched silica layers. When these layers are in contact with a solution, they are subject to a differential re-hydration that may result in cracking and detachment of scales. The purpose of this investigation is to identify testing conditions and parameters that can be used as indicators of an incipient delamination process. Extractions with 0.9% KCl solution for 1 h at 121 °C can be used to simulate a long-term contact with aggressive pharmaceutical preparations, while SiO(2) concentration in the extract solution can be taken as an index of glass dissolution. The conclusions developed by this study can provide pharmaceutical manufacturers with information needed to help prevent glass delamination in their processes.

摘要

未标注

药用玻璃的分层是一个严重问题,因为它会导致小瓶中出现玻璃颗粒,这一问题近年来已迫使多次药品召回。在I型药用玻璃瓶中,分层通常发生在底部和肩部,在转换过程中的大量火焰处理会促使碱和硼酸盐物质强烈蒸发,并形成高度富集的二氧化硅层。与溶解在碱性介质中的肠胃外制剂接触会增加玻璃腐蚀速率,而这些层的不同程度水合作用会导致薄片脱落。本研究的目的是调查萃取溶液的pH值和组成对不同类型玻璃分层倾向的影响。在121°C下对不同类型玻璃使用不同萃取介质(包括柠檬酸和戊二酸等有机萃取剂)进行反复高压灭菌萃取。当小瓶与碱性溶液及类似的侵蚀性介质接触时,二氧化硅萃取值的增加表明玻璃发生腐蚀,进一步分层的风险也在增加。在这种条件下,33号膨胀玻璃被广泛腐蚀,与其他类型玻璃相比,显示出高二氧化硅浓度和严重剥落。经硫处理的玻璃也显示出早期剥落,即使二氧化硅浓度非常低。用戊二酸和柠檬酸进行萃取时也观察到类似的排序,但二氧化硅浓度水平要高得多。用0.9%氯化钾溶液进行萃取可作为一种加速试验,以突出玻璃分层的倾向,但在任何情况下都不能保证玻璃在接触药品时不会分层,药品的萃取能力需要逐案研究。

摘要

注射用药品制造商如何防止玻璃分层?分层问题很严重,因为它会导致小瓶中出现玻璃颗粒,这一问题近年来已迫使多次药品召回。为解决这一问题,制药和生物制药制造商需要了解玻璃分层的原因。最近因灌装液中存在颗粒而导致产品召回的案例涉及硼硅酸盐玻璃容器,这些容器盛装的药品含有已知会腐蚀玻璃并溶解二氧化硅基质的活性成分。有时这些成分溶解在碱性介质中,会显著增加玻璃腐蚀并可能导致该问题。由于这一作用受时间和温度强烈影响,剥落可能仅在储存期间长时间孵育后才会显现,并且需要系统监测才能在早期阶段检测到。如果灌装液的性质是该现象的驱动力,那么其他因素也至关重要。小瓶成型过程中产生的表面形态是一个关键问题,它是切割步骤和底部成型中较高成型温度的函数。分层通常发生在小瓶的底部和肩部,大量火焰处理会促使碱和硼酸盐物质强烈蒸发,并形成高度富集的二氧化硅层。当这些层与溶液接触时,它们会经历不同程度的再水合作用,这可能导致鳞片开裂和脱落。本研究的目的是确定可用作初始分层过程指标的测试条件和参数。在121°C下用0.9%氯化钾溶液萃取1小时可用于模拟与侵蚀性药物制剂的长期接触,而萃取溶液中的二氧化硅浓度可作为玻璃溶解的指标。本研究得出的结论可为制药制造商提供所需信息,以帮助防止其生产过程中的玻璃分层。

相似文献

1
Delamination propensity of pharmaceutical glass containers by accelerated testing with different extraction media.通过使用不同萃取介质的加速试验评估药用玻璃容器的分层倾向。
PDA J Pharm Sci Technol. 2012 Mar-Apr;66(2):116-25. doi: 10.5731/pdajpst.2012.00853.
2
Complexing Agents and pH Influence on Chemical Durability of Type I Molded Glass Containers.络合剂和pH值对I型模制玻璃容器化学耐久性的影响
PDA J Pharm Sci Technol. 2017 Jul-Aug;71(4):306-316. doi: 10.5731/pdajpst.2016.006304.
3
Novel Mechanism of Glass Delamination in Type 1A Borosilicate Vials Containing Frozen Protein Formulations.含冷冻蛋白质制剂的1A型硼硅玻璃小瓶中玻璃分层的新机制
PDA J Pharm Sci Technol. 2013 Jul-Aug;67(4):323-35. doi: 10.5731/pdajpst.2013.00925.
4
A Contribution to an Understanding of Complexing Agents and Salt Solutions Reaction Mechanism on Chemical Attack of Type I Molded Glass Containers.对理解络合剂和盐溶液对 I 型模制玻璃容器化学侵蚀的反应机制的贡献
PDA J Pharm Sci Technol. 2019 Nov-Dec;73(6):538-551. doi: 10.5731/pdajpst.2018.009506. Epub 2019 May 17.
5
Delamination Propensity of Glass Containers for Pharmaceutical Use: A Round Robin Activity Looking for a Predictive Test.药用玻璃容器的分层倾向:一项寻找预测性测试的循环试验活动
PDA J Pharm Sci Technol. 2018 Nov-Dec;72(6):553-565. doi: 10.5731/pdajpst.2018.008599. Epub 2018 Jun 27.
6
Determining the delamination propensity of pharmaceutical glass vials using a direct stress method.使用直接应力法测定药用玻璃瓶的分层倾向。
PDA J Pharm Sci Technol. 2013 Jan-Feb;67(1):35-42. doi: 10.5731/pdajpst.2013.00900.
7
Filtration of Glass Delamination Particles with West Pharmaceutical Vial Adapters.使用西氏制药瓶适配器过滤玻璃分层颗粒。
PDA J Pharm Sci Technol. 2015 Nov-Dec;69(6):669-76. doi: 10.5731/pdajpst.2015.01076.
8
Comparative Leachable Study of Glass Vials to Demonstrate the Impact of Low Fill Volume.玻璃小瓶的对比可浸出物研究,以证明低灌装量的影响。
PDA J Pharm Sci Technol. 2019 Jul-Aug;73(4):345-355. doi: 10.5731/pdajpst.2018.009472. Epub 2019 Feb 15.
9
Observation and Mitigation of Lamellar Silica Particles Formed in Pharmaceutical Products Packaged in Glass Vials.观察和减轻玻璃小瓶包装的药品中形成的层状硅颗粒。
J Pharm Sci. 2022 Dec;111(12):3275-3286. doi: 10.1016/j.xphs.2022.09.005. Epub 2022 Sep 16.
10
Comparison of Acid Titration, Conductivity, Flame Photometry, ICP-MS, and Accelerated Lamellae Formation Techniques in Determining Glass Vial Quality.酸滴定法、电导率法、火焰光度法、电感耦合等离子体质谱法及加速薄片形成技术在玻璃小瓶质量测定中的比较
PDA J Pharm Sci Technol. 2016 May-Jun;70(3):248-55. doi: 10.5731/pdajpst.2015.006056. Epub 2016 Apr 18.

引用本文的文献

1
Alteration of Sulfur-Bearing Silicate-Phosphate (Agri)Glasses in Soil Environment: Structural Characterization and Chemical Reactivity of Fertilizer Glasses: Insights from 'In Vitro' Studies.土壤环境中含硫硅酸盐 - 磷酸盐(农业用)玻璃的变化:肥料玻璃的结构表征与化学反应性:“体外”研究的见解
Molecules. 2025 Apr 9;30(8):1684. doi: 10.3390/molecules30081684.
2
Investigation of long-term pressure on primary packaging materials and a biologic drug product for injection with a novel autoinjector concept.采用新型自动注射器概念对注射用生物药品的一级包装材料进行长期压力研究。
Drug Deliv Transl Res. 2025 Feb;15(2):577-595. doi: 10.1007/s13346-024-01612-y. Epub 2024 May 10.
3
Fast Blob and Air Line Defects Detection for High Speed Glass Tube Production Lines.
高速玻璃管生产线的快速斑点和空气管线缺陷检测
J Imaging. 2021 Oct 25;7(11):223. doi: 10.3390/jimaging7110223.
4
Inositol in preterm infants at risk for or having respiratory distress syndrome.患有或有患呼吸窘迫综合征风险的早产儿体内的肌醇
Cochrane Database Syst Rev. 2019 Jul 8;7(7):CD000366. doi: 10.1002/14651858.CD000366.pub4.
5
Effects of Myo-inositol on Type 1 Retinopathy of Prematurity Among Preterm Infants <28 Weeks' Gestational Age: A Randomized Clinical Trial.肌醇对 28 周以下早产儿 1 型早产儿视网膜病变的影响:一项随机临床试验。
JAMA. 2018 Oct 23;320(16):1649-1658. doi: 10.1001/jama.2018.14996.
6
Impact of Vial Washing and Depyrogenation on Surface Properties and Delamination Risk of Glass Vials.瓶洗和去热原对玻璃小瓶表面性能和分层风险的影响。
Pharm Res. 2018 May 23;35(7):146. doi: 10.1007/s11095-018-2421-6.
7
Glass delamination: a comparison of the inner surface performance of vials and pre-filled syringes.玻璃分层:小瓶和预填充注射器内表面性能的比较
AAPS PharmSciTech. 2014 Dec;15(6):1398-409. doi: 10.1208/s12249-014-0167-y. Epub 2014 Jun 18.